Le dépistage néonatal en France : approche biologique. Rev Francoph des Lab, vol.2018, pp.30-35, 2018. ,
Newborn screening programmes in Europe; arguments and efforts regarding harmonization. Part 1. From blood spot to screening result, J Inherit Metab Dis, vol.35, issue.4, pp.603-614, 2012. ,
Medium chain Acyl-CoA dehydrogenase deficiency in pennsylvania:Neonatal screening shows highincidence and unexpected mutation frequencies, Pediatr Res, vol.37, issue.5, pp.675-683, 1995. ,
Déficit en acyl-CoAdéshydrogénase des acides gras à chaîne moyenne (MCAD) : consensus français pour le dépistage, le diagnostic, et la prise en charge. Arch Pédiatrie, vol.19, pp.184-93, 2012. ,
A general introduction to the biochemistry of mitochondrial fatty acid ?-oxidation, J Inherit Metab Dis, vol.33, issue.5, pp.469-77, 2010. ,
Fatty Acid Beta-Oxidation Disorders: A Brief Review, Ann Neurosci, vol.23, issue.1, pp.51-56, 2016. ,
Medium-Chain Acyl-CoA Dehydrogenase Deficiency in Children with Non-Ketotic Hypoglycemia and Low Carnitine Levels, Pediatr Res, vol.17, issue.11, pp.877-84, 1983. ,
La ?-oxydation mitochondriale des acides gras : une voie métabolique essentielle du fonctionnement musculaire. Arch Pédiatrie, vol.9, pp.175-183, 2002. ,
Carnitine function and requirements during the life cycle, FASEB J, vol.6, issue.15, pp.3379-86, 1992. ,
Carnitine transport and fatty acid oxidation, Biochim Biophys Acta, vol.1863, issue.10, pp.2422-2457, 2016. ,
Mammalian mitochondrial ? -oxidation ,
, , vol.320, pp.345-57, 1996.
Peroxisomal ?-oxidation-A metabolic pathway with multiple functions, Biochim Biophys Acta -Mol Cell Res, vol.1763, issue.12, pp.1413-1439, 2006. ,
Follow-up of fatty acid ?-oxidation disorders in expanded newborn screening era, Eur J Pediatr, vol.178, issue.3, pp.387-94, 2019. ,
Fatty Acid Oxidation disorders, Indian J Pract Pediatr, vol.12, issue.2, pp.181-184, 2010. ,
Mitochondrial dysfunction in fatty acid oxidation disorders: insights from human and animal studies, Biosci Rep, vol.36, issue.1, p.281, 2015. ,
Child Neurology: Medium-chain acyl-coenzyme A dehydrogenase deficiency, Neurology, vol.85, issue.4, pp.37-40, 2015. ,
Suberylglycine excretion in the urine from a patient with dicarboxylic aciduria, Clin Chim Acta, vol.70, issue.3, pp.417-442, 1976. ,
Non-ketotic C6-C10-dicarboxylic aciduria: biochemical investigations of two cases, Clin Chim Acta, vol.102, issue.2-3, pp.179-89, 1980. ,
In vitro fibroblast studies in a patient with C6-C10-dicarboxylic aciduria: evidence for a defect in general acyl-CoA dehydrogenase, Clin Chim Acta, vol.126, issue.1, pp.53-67, 1982. ,
Deficiency of medium chain fatty acylcoenzyme A dehydrogenase presenting as the sudden infant death syndrome, BMJ, vol.288, issue.6422, pp.976-976, 1984. ,
Recognition of medium-chain acyl-CoA dehydrogenase deficiency in asymptomatic siblings of children dying of sudden infant death or Reye-like syndromes, J Pediatr, vol.108, issue.1, pp.13-21, 1986. ,
Mutations in the medium chain acyl-CoA dehydrogenase (MCAD) gene, Hum Mutat, vol.1, issue.4, pp.271-280, 1992. ,
Specific diagnosis of medium-chain acyl-CoA dehydrogenase (MCAD) deficiency in dried blood spots by a polymerase chain reaction (PCR) assay detecting a point-mutation (G985) in the MCAD gene, Clin Chim Acta, vol.203, issue.1, pp.23-34, 1991. ,
Molecular characterization of inherited medium-chain acyl-CoA dehydrogenase deficiency, Proc Natl Acad Sci, vol.87, issue.23, pp.9236-9276, 1990. ,
Identification of a common mutation in patients with medium-chain acyl-CoA dehydrogenase deficiency, Biochem Biophys Res Commun, vol.171, issue.1, pp.498-505, 1990. ,
Mutations in medium chain acyl-CoA dehydrogenase deficiency, Lancet, vol.336, issue.8717, pp.748-757, 1990. ,
Prenatal diagnosis of medium-chain acyl-coenzyme A dehydrogenase deficiency, Prenat Diagn, vol.7, issue.2, pp.135-176, 1987. ,
Prenatal diagnosis of medium-chain acyl-CoA dehydrogenase (MCAD) deficiency in a family with a previous fatal case of sudden unexpected death in childhood, Prenat Diagn, vol.15, issue.1, pp.82-88, 1995. ,
Preimplantation genetic diagnosis for medium-chain acyl-CoA dehydrogenase (MCAD) deficiency ,
, Molecular Human Reproduction, vol.6, 2000.
Rapid diagnosis of MCAD deficiency: quantitative analysis of octanoylcarnitine and other acylcarnitines in newborn blood spots by tandem mass spectrometry, Clin Chem, vol.43, issue.11, pp.2106-2119, 1997. ,
, Haute Autorité de Santé -Évaluation de l'extension du dépistage néonatal à une ou plusieurs erreurs innées du métabolisme par spectrométrie de masse en tandem. 1er volet: déficit en MCAD
Medium-chain acyl-CoA dehydrogenase deficiency: molecular aspects, Eur J Pediatr, vol.151, issue.3, pp.154-163, 1992. ,
Medium-chain acyl-coenzyme A dehydrogenase deficiency: clinical course in 120 affected children, J Pediatr, vol.124, issue.3, pp.409-424, 1994. ,
The epidemiology of medium chain acyl-CoA dehydrogenase deficiency: an update, Genet Med, vol.8, issue.4, pp.205-217, 2006. ,
Medium-Chain Acyl-Coenzyme A Dehydrogenase Deficiency ,
Newborn screening for medium-chain acyl-CoA dehydrogenase deficiency: A global perspective, J Inherit Metab Dis, vol.29, issue.2-3, pp.370-377, 2006. ,
Molecular Survey of a Prevalent Mutation, 985A-to-G Transition, and Identification of Five Infrequent Mutations in the Medium-Chain Acyl-CoA Dehydrogenase (MCAD) Gene in 55 Patients with MCAD Deficiency ,
, Am. J. Hum. Genet, vol.49, 1991.
The tissue-specific expression and developmental regulation of two nuclear genes encoding rat mitochondrial proteins. Medium chain acyl-CoA dehydrogenase and mitochondrial malate dehydrogenase, J Biol Chem, vol.264, issue.32, pp.18921-18926, 1989. ,
Crystal structures of medium-chain acyl-CoA dehydrogenase from pig liver mitochondria with and without substrate, Proc Natl Acad Sci, vol.90, issue.16, pp.7523-7530, 1993. ,
Medium-Chain Acyl-CoA Dehydrogenase (MCAD) Deficiency: The Prevalent Mutation G985 (K304E) Is Subject to a Strong Founder Effect from Northwestern Europe, Hum Hered, vol.43, issue.6, pp.342-50, 1993. ,
Medium-Chain Acyl-CoA Dehydrogenase (MCAD) Mutations Identified by MS/MS-Based Prospective Screening of Newborns Differ from Those Observed in Patients with Clinical Symptoms: Identification and Characterization of a New, Prevalent Mutation That Results i ,
, Am. J. Hum. Genet, vol.68, 2001.
The Domain-Specific and Temperature-Dependent Protein Misfolding Phenotype of Variant Medium-Chain acyl-CoA Dehydrogenase, PLoS One, vol.9, issue.4, p.93852, 2009. ,
Protein misfolding is the molecular mechanism underlying MCADD identified in newborn screening, Hum Mol Genet, vol.18, issue.9, pp.1612-1635, 2009. ,
Genetic defects in fatty acid beta-oxidation and acyl-CoA dehydrogenases. Molecular pathogenesis and genotype-phenotype relationships, Eur J Biochem, vol.271, issue.3, pp.470-82, 2004. ,
Co-overexpression of bacterial GroESL chaperonins partly overcomes non-productive folding and tetramer assembly of E. coli-expressed human medium-chain acyl-CoA dehydrogenase (MCAD) carrying the prevalent disease-causing K304E mutation, Biochim Biophys Acta, vol.1182, issue.3, pp.264-74, 1993. ,
Prevalent mutations in fatty acid oxidation disorders: diagnostic considerations, Eur J Pediatr, vol.159, pp.213-221, 2000. ,
Medium chain acyl-CoA dehydrogenase deficiency, Arch Dis Child, vol.67, issue.1, pp.142-147, 1992. ,
Morbidity and mortality in medium chain acyl coenzyme A dehydrogenase deficiency, Arch Dis Child, vol.70, issue.5, pp.410-412, 1994. ,
The clinical manifestation of MCAD deficiency: challenges towards adulthood in the screened population, J Inherit Metab Dis, vol.33, issue.5, pp.513-533, 2010. ,
Sudden child death and "healthy" affected family members with medium-chain acyl-coenzyme A dehydrogenase deficiency, Pediatrics, vol.78, issue.6, pp.1052-1059, 1986. ,
Evidence that antioxidants prevent the inhibition of Na+,K(+)-ATPase activity induced by octanoic acid in rat cerebral cortex in vitro, Neurochem Res, vol.28, issue.8, pp.1255-63, 2003. ,
Inhibition of energy metabolism in cerebral cortex of young rats by the medium-chain fatty acids accumulating in MCAD deficiency, Brain Res, vol.1030, issue.1, pp.141-51, 2004. ,
K+ ATPase activity is markedly reduced by cis-4-decenoic acid in synaptic plasma membranes from cerebral cortex of rats, Exp Neurol, vol.197, issue.1, pp.143-152, 2006. ,
Oxidative stress induction by cis-4-decenoic acid: relevance for MCAD deficiency, Free Radic Res, vol.41, issue.11, pp.1261-72, 2007. ,
Evidence that the major metabolites accumulating in medium-chain acyl-CoA dehydrogenase deficiency disturb mitochondrial energy homeostasis in rat brain, Brain Res, vol.1296, pp.117-143, 2009. ,
Regional Cerebral Na+K+ ATPase Activity following Octanoate Administration, Pediatr Res, vol.14, issue.6, pp.844-849, 1980. ,
Toxicity of octanoate and decanoate in rat peripheral tissues: evidence of bioenergetic dysfunction and oxidative damage induction in liver and skeletal muscle, Mol Cell Biochem, vol.361, issue.1-2, pp.329-364, 2012. ,
Mechanistic Bases of Neurotoxicity Provoked by Fatty Acids Accumulating in MCAD and LCHAD Deficiencies, J inborn errors Metab Screen, vol.5, pp.1-7, 2017. ,
Adult presentations of medium-chain acyl-CoA dehydrogenase deficiency (MCADD), J Inherit Metab Dis, vol.32, issue.6, pp.675-83, 2009. ,
Adult presentation of MCAD deficiency revealed by coma and severe arrythmias, Intensive Care Med, vol.29, issue.9, pp.1594-1601, 2003. ,
Neonatal symptoms in medium chain acyl coenzyme A dehydrogenase deficiency. Arch Dis Child, vol.69, pp.292-296, 1993. ,
Medium-chain and long-chain acyl CoA dehydrogenase deficiency: clinical, pathologic and ultrastructural differentiation from Reye's syndrome, Hepatology, vol.6, issue.6, pp.1270-1278 ,
The natural history of medium-chain acyl CoA dehydrogenase deficiency in the Netherlands: clinical presentation and outcome, J Pediatr, vol.148, issue.5, pp.665-70, 2006. ,
Neuropsychological functioning in children with medium chain acyl coenzyme a dehydrogenase deficiency (MCADD): the impact of early diagnosis and screening on outcome, vol.15, pp.8-20, 2009. ,
Rhabdomyolysis and acute encephalopathy in late onset medium chain acyl-CoA dehydrogenase deficiency, J Neurol Neurosurg Psychiatry, vol.58, issue.2, pp.209-223, 1995. ,
Acute liver failure in pregnancy associated with maternal MCAD deficiency, J Inherit Metab Dis, vol.30, issue.1, pp.103-103, 2007. ,
Screening for medium-chain acyl CoA dehydrogenase deficiency: current perspectives, Res Reports Neonatol, vol.6, p.1, 2016. ,
Medium-chain acyl-CoA dehydrogenase deficiency: sudden and unexpected death of a 45 year old woman, Genet Med, vol.1, issue.6, pp.293-297, 1999. ,
Identification of a Novel Mutation in Patients with Medium-Chain Acyl-CoA Dehydrogenase Deficiency, Mol Genet Metab, vol.69, issue.3, pp.259-62, 2000. ,
Ketonuria and medium-chain acyl-CoA dehydrogenase deficiency, J Inherit Metab Dis, vol.18, issue.1, pp.98-107, 1995. ,
Hyperuricaemia and medium-chain acyl-CoA dehydrogenase deficiency, J Inherit Metab Dis, vol.20, issue.6, pp.842-845, 1997. ,
Hyperuricemia in medium-chain acyl-coenzyme A dehydrogenase deficiency, J Pediatr, vol.120, issue.3, pp.444-450, 1992. ,
Implications of impaired ketogenesis in fatty acid oxidation disorders, Prostaglandins Leukot Essent Fat Acids, vol.70, issue.3, pp.293-308, 2004. ,
Octanoic acidemia and octanoylcarnitine excretion with dicarboxylic aciduria due to defective oxidation of medium-chain fatty acids, J Pediatr, vol.107, issue.3, pp.397-404, 1985. ,
Medium-Chain Acyl-CoA Dehydrogenase (MCAD) Deficiency: Diagnosis by Acylcarnitine Analysis in Blood ,
, Am. J. Hum. Genet, vol.52, 1993.
Allelic diversity in MCAD deficiency: The biochemical classification of 54 variants identified during 5years of ACADM sequencing, Mol Genet Metab, vol.100, issue.3, pp.241-50, 2010. ,
Medium-Chain Acyl-Coenzyme A Dehydrogenase Deficiency ,
The inborn errors of mitochondrial fatty acid oxidation, J Inherit Metab Dis, vol.10, pp.159-200, 1987. ,
Retrospective biochemical screening of fatty acid oxidation disorders in postmortem livers of 418 cases of sudden death in the first year of life, J Pediatr, vol.132, issue.6, pp.924-957, 1998. ,
General (medium-chain) acyl-CoA dehydrogenase deficiency (non-ketotic dicarboxylic aciduria): quantitative urinary excretion pattern of 23 biologically significant organic acids in three cases, Clin Chim Acta, vol.132, issue.2, pp.181-91, 1983. ,
The differential diagnosis of dicarboxylic aciduria, J Inherit Metab Dis, vol.7, issue.1, pp.48-51, 1984. ,
Abnormal urinary excretion of unsaturated dicarboxylic acids in patients with medium-chain acyl-CoA dehydrogenase deficiency, J Lipid Res, vol.31, issue.5, pp.763-71, 1990. ,
Medium-Chain Acyl-CoA Dehydrogenase Deficiency, N Engl J Med, vol.319, issue.20, pp.1308-1321, 1988. ,
Diagnosis of medium chain acyl-CoA dehydrogenase deficiency by stable isotope dilution analysis of urinary acylglycines: retrospective and prospective studies, and comparison of its accuracy to acylcarnitine identification by FAB/mass spectrometry, Prog Clin Biol Res, vol.321, pp.411-419, 1990. ,
A novel method for quantitation of acylglycines in human dried blood spots by UPLC-tandem mass spectrometry, Clin Biochem, vol.54, pp.131-139, 2018. ,
A method for quantitative acylcarnitine profiling in human skin fibroblasts using unlabelled palmitic acid: diagnosis of fatty acid oxidation disorders and differentiation between biochemical phenotypes of MCAD deficiency, Biochim Biophys Acta, vol.1584, issue.2-3, pp.91-99, 2002. ,
Development of a Tandem Mass Spectrometry Method for Rapid Measurement of Medium-and Very-Long-Chain Acyl-CoA Dehydrogenase Activity in Fibroblasts, JIMD reports, pp.71-79, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01848150
The enzymology of mitochondrial fatty acid beta-oxidation and its application to follow-up analysis of positive neonatal screening results, J Inherit Metab Dis, vol.33, issue.5, pp.479-94, 2010. ,
Sudden death beyond SIDS, Pediatr Pathol Lab Med, vol.16, issue.4, pp.691-694 ,
Molecular and functional characterisation of mild MCAD deficiency, Hum Genet, vol.108, issue.5, pp.404-412, 2001. ,
Prise en charge en cas de mort inattendue du nourrisson (moins de 2 ans, 2007. ,
, ClinVar -NCBI
Mitochondrial fatty acid oxidation defects-remaining challenges, J Inherit Metab Dis, vol.31, issue.5, pp.643-57, 2008. ,
Population spectrum of ACADM genotypes correlated to biochemical phenotypes in newborn screening for medium-chain acyl-CoA dehydrogenase deficiency, Hum Mutat, vol.25, issue.5, pp.443-52, 2005. ,
A novel tandem mass spectrometry method for rapid confirmation of medium-and very long-chain acyl-CoA dehydrogenase deficiency in newborns, Jul, vol.30, issue.7, p.6449, 2009. ,
Medium-Chain Acyl-CoA Dehydrogenase (MCAD) Mutations Identified by MS/MS-Based Prospective Screening of Newborns Differ from Those Observed in Patients with Clinical Symptoms: Identification and Characterization of a New, Prevalent Mutation That Results i, Am J Hum Genet, vol.68, issue.6, pp.1408-1426, 2001. ,
Functional Effects of Different Medium-Chain Acyl-CoA Dehydrogenase Genotypes and Identification of Asymptomatic Variants, PLoS One, vol.7, issue.9, p.45110, 2012. ,
The Y42H mutation in medium-chain acyl-CoA dehydrogenase, which is prevalent in babies identified by MS/MSbased newborn screening, is temperature sensitive, Eur J Biochem, vol.271, issue.20, pp.4053-63, 2004. ,
Prevalence of K329E mutation in medium-chain acyl-CoA dehydrogenase gene determined from Guthrie cards, Lancet, vol.338, issue.8766, pp.552-555, 1991. ,
Genotypic differences of MCAD deficiency in the Asian population: novel genotype and clinical symptoms preceding newborn screening notification, Genet Med, vol.7, issue.5, pp.339-382 ,
Most cases of medium-chain acyl-CoA dehydrogenase deficiency escape detection in France, Hum Genet, vol.97, issue.3, pp.367-375, 1996. ,
Medium chain acyl-CoA dehydrogenase deficiency: Human genome epidemiology review, Genet Med, vol.1, issue.7, pp.332-341, 1999. ,
Newborn screening for medium chain acyl CoA dehydrogenase deficiency, Arch Dis Child, vol.94, issue.3, pp.235-243, 2009. ,
Safe and unsafe duration of fasting for children with MCAD deficiency, Eur J Pediatr, vol.166, issue.1, pp.5-11, 2007. ,
Tolerance to fast: rational and practical evaluation in children with hypoketonaemia, J Inherit Metab Dis, vol.32, issue.2, pp.214-221, 2009. ,
In vitro and in vivo consequences of variant medium-chain acyl-CoA dehydrogenase genotypes, Orphanet J Rare Dis, vol.8, issue.1, p.43, 2013. ,
Morbidity and mortality among exclusively breastfed neonates with medium-chain acyl-CoA dehydrogenase deficiency, Genet Med, vol.18, issue.12, pp.1315-1324, 2016. ,
Early recognition of metabolic decompensation, Arch Dis Child, vol.76, issue.6, pp.555-561, 1997. ,
l-Carnitine prevents mitochondrial damage induced by octanoic acid in the rat choroid plexus, Brain Res, vol.536, issue.1-2, pp.335-343, 1990. ,
Prolonged moderate-intensity exercise without and with L-carnitine supplementation in patients with MCAD deficiency, J Inherit Metab Dis, vol.29, issue.5, pp.631-637, 2006. ,
L-Carnitine and exercise tolerance in medium-chain acyl-coenzyme A dehydrogenase (MCAD) deficiency: A pilot study, J Inherit Metab Dis, vol.28, issue.2, pp.141-52, 2005. ,
Medium-chain acyl-CoA dehydrogenase deficiency: metabolic effects and therapeutic efficacy of long-term L-carnitine supplementation, J Inherit Metab Dis, vol.12, issue.2, pp.112-121, 1989. ,
Renal Handling of Carnitine in Secondary Carnitine Deficiency Disorders, Pediatr Res, vol.34, issue.1, pp.89-96, 1993. ,
Cofactors and metabolites as potential stabilizers of mitochondrial acyl-CoA dehydrogenases, Biochim Biophys Acta -Mol Basis Dis, vol.1812, issue.12, pp.1658-63, 2011. ,
Diagnosis of medium-chain acyl-CoA dehydrogenase deficiency in lymphocytes and liver by a gas chromatographic method: the effect of oral riboflavin supplementation, Pediatr Res, vol.31, issue.1, pp.39-42, 1992. ,
Experimental evidence for protein oxidative damage and altered antioxidant defense in patients with medium-chain acyl-CoA dehydrogenase deficiency, J Inherit Metab Dis, vol.37, issue.5, pp.783-792, 2014. ,
Mitochondrial function and toxicity: Role of the B vitamin family on mitochondrial energy metabolism, Chem Biol Interact, vol.163, issue.1-2, pp.94-112, 2006. ,
Prospective surveillance study of medium chain acyl-CoA dehydrogenase deficiency in the UK. Arch Dis Child, vol.79, pp.116-125, 1998. ,
Follow-up status during the first 5 years of life for metabolic disorders on the federal Recommended Uniform Screening Panel, Genet Med, vol.20, issue.8, pp.831-840, 2018. ,
Neonatal screening for inborn errors of metabolism: cost, yield and outcome ,
, ):i-iv, Health Technol Assess, issue.7, pp.1-202, 1997.
Economics of tandem mass spectrometry screening of neonatal inherited disorders, Int J Technol Assess Health Care, vol.22, issue.3, pp.321-327, 2006. ,
Cost-effectiveness of neonatal screening for medium chain acyl-CoA dehydrogenase deficiency: the homogeneous population of The Netherlands, J Pediatr, vol.151, issue.2, pp.1-3, 2007. ,
Outcome of neonatal screening for medium-chain acyl-CoA dehydrogenase deficiency in Australia: a cohort study, Lancet, vol.369, issue.9555, pp.37-42, 2007. ,
Efficacy and outcome of expanded newborn screening for metabolic diseases -Report of 10 years from South-West Germany *, Orphanet J Rare Dis, vol.6, issue.1, p.44, 2011. ,
Medium-Chain Acyl-CoA Deficiency: Outlines from Newborn Screening, In Silico Predictions, and Molecular Studies. Sci World J, vol.2013, pp.1-8, 2013. ,
An audit of newborn screening procedure: impact on infants presenting clinically before results are available, Mol Genet Metab, vol.114, issue.3, pp.403-411, 2015. ,
A Nationwide Retrospective Observational Study Of Population Newborn Screening For Medium-Chain Acyl-CoA Dehydrogenase (MCAD) Deficiency In The Netherlands, J Inherit Metab Dis, 2019. ,
Clinical efficacy and costeffectiveness of newborn screening for medium chain acyl-CoA dehydrogenase deficiency using tandem mass spectrometry, Clin Biochem, vol.40, issue.3-4, pp.235-276, 2007. ,
Newborn Screening by Tandem Mass Spectrometry for Medium-Chain Acyl-CoA Dehydrogenase Deficiency: A Cost-Effectiveness Analysis, Pediatrics, vol.112, issue.5, pp.1005-1020, 2003. ,
Reduced incidence of severe metabolic crisis or death in children with medium chain acyl-CoA dehydrogenase deficiency homozygous for c.985A>G identified by neonatal screening, Mol Genet Metab, vol.85, issue.2, pp.157-166, 2005. ,
Spectrum of Medium-Chain Acyl-CoA Dehydrogenase Deficiency Detected by Newborn Screening, Pediatrics, vol.121, issue.5, pp.1108-1122, 2008. ,
,
, Ann Biol Clin (Paris), vol.58, issue.3, pp.267-76, 2000.
Le prélèvement sanguin sur papier buvard : Une révolution de la biologie médicale en marche ?, Ann Biol Clin, vol.73, issue.1, pp.25-37, 2015. ,
Présentation de l'état des lieux du dépistage néonatal en France. médecine/sciences, vol.34, pp.19-21, 2018. ,
Dépistage néonatal en France : quel avenir ? Arch Pédiatrie, vol.21, pp.813-818, 2014. ,
Psychological Effects of False-Positive Results in Expanded Newborn Screening in China, PLoS One, vol.7, p.36235, 2012. ,
Guide pour l'accréditation des laboratoires de dépistage néonatal selon la Norme NF EN ISO 15189 -Partie 2 : Phase analytique, 2014. ,
PRINCIPLES AND PRACTICE OF SCREENING FOR DISEASE ,
, Haute Autorité de Santé -Évaluation a priori de l'extension du dépistage néonatal à une ou plusieurs erreurs innées du métabolisme par spectrométrie de masse en tandem
Newborn screening for metabolic disorders, J Pediatr, vol.148, issue.5, pp.577-584, 2006. ,
Spectrométrie de masse en tandem et dépistage néonatal des erreurs innées du métabolisme : Rapport technique, 2007. ,
Neonatal screening for medium-chain acyl-CoA dehydrogenase (MCAD) deficiency in The Netherlands: the importance of enzyme analysis to ascertain true MCAD deficiency, J Inherit Metab Dis, vol.31, issue.1, pp.88-96, 2008. ,
Sequencing from dried blood spots in infants with "false positive" newborn screen for MCAD deficiency, Mol Genet Metab, vol.108, issue.1, pp.51-56, 2013. ,
Medium-chain acyl-CoA dehydrogenase deficiency: Genotype-biochemical phenotype correlations, Mol Genet Metab, vol.87, issue.1, pp.32-41, 2006. ,
Lack of genotype-phenotype correlations and outcome in MCAD deficiency diagnosed by newborn screening in New York State, Mol Genet Metab, vol.99, issue.3, pp.263-271, 2010. ,
221 newbornscreened neonates with medium-chain acyl-coenzyme A dehydrogenase deficiency: Findings from the Inborn Errors of Metabolism Collaborative, Mol Genet Metab, vol.119, issue.1-2, pp.75-82, 2016. ,
Fatty acid oxidation disorders: outcome and long-term prognosis, J Inherit Metab Dis, vol.33, issue.5, pp.501-507, 2010. ,
Sudden death in medium chain acyl-coenzyme a dehydrogenase deficiency (MCADD) despite newborn screening, Mol Genet Metab, vol.101, issue.1, pp.33-42, 2010. ,
Risk stratification by residual enzyme activity after newborn screening for medium-chain acyl-CoA dehyrogenase deficiency: data from a cohort study, Orphanet J Rare Dis, vol.7, issue.1, p.30, 2012. ,
Evaluation of newborn screening for medium chain acyl-CoA dehydrogenase deficiency in 275 000 babies. Arch Dis Child -Fetal Neonatal Ed, vol.85, pp.105-109, 2001. ,
Tandem mass spectrometric analysis for amino, organic, and fatty acid disorders in newborn dried blood spots: A two-year summary from the New England newborn screening program, Clin Chem, vol.47, issue.11, pp.1945-55, 2001. ,
Newborn screening for MCAD deficiency: experience of the first three years in British Columbia, Canada. Can J Public Health, vol.99, issue.4, pp.276-80, 2008. ,
Expanded newborn screening for inborn errors of metabolism by electrospray ionization-tandem mass spectrometry: Results, outcome, and implications, Pediatrics, vol.111, issue.6 I, pp.1399-406, 2003. ,
Cost-effectiveness analysis of universal newborn screening for medium chain acyl-CoA dehydrogenase deficiency in France, BMC Pediatr, vol.12, issue.1, p.60, 2012. ,
Marché public : Fourniture, installation et maintenance de spectromètres de masses en tandem et fourniture de réactifs permettant la réalisation du dépistage néonatal de la phénylcétonurie et du déficit en MCAD -Paris, 2019. ,
Manuel d'utilisation pour le dosage par LC-MS/MS. MassChrom® Acides aminés et acylcarnitines sur sang séché (sans dérivation), 2020. ,
Newborn screening for medium chain acyl-CoA ehydrogenase deficiency in England: Prevalence, redictive value and test validity based on 1.5 million creened babies ,
, Journal of Medical Screening, vol.18, pp.173-81, 2011.
New Ratios for Performance Improvement for Identifying Acyl-CoA Dehydrogenase Deficiencies in Expanded Newborn Screening: A Retrospective Study. Front Genet, vol.10, p.811, 2019. ,
Sudden unexpected infant death (SUDI) in a newborn due to medium chain acyl CoA dehydrogenase (MCAD) deficiency with an unusual severe genotype, 2012. ,
Newborn screening for medium-chain acyl-CoA dehydrogenase deficiency: Regional experience and high incidence of carnitine deficiency, Orphanet J Rare Dis, vol.8, issue.1, p.102, 2013. ,
Inborn errors of metabolism in the United Arab Emirates: Disorders detected by newborn screening, JIMD Reports, pp.127-162, 2011. ,
Biochemical screening of 504,049 newborns in Denmark, the Faroe Islands and Greenland -Experience and development of a routine program for expanded newborn screening, Mol Genet Metab, vol.107, issue.3, pp.281-93, 2012. ,
Acylcarnitine Profi les during Carnitine Loading and Fasting Tests in a, Japanese Patient with Medium-Chain Acyl-CoA Dehydrogenase Defi ciency, vol.213, 2007. ,
Clinical relevance of the discrepancy in phenylalanine concentrations analyzed using tandem mass spectrometry compared with ion-exchange chromatography in phenylketonuria, Mol Genet Metab Reports, vol.132 ,